fda approves semaglutide for cardiovascular risk reduction Wegovy, the weight-loss medication, gets approval use as heart disease prevention drug FDA approves Ozempic® (semaglutide) as

Earlier this month, new research published in eClinicalMedicine showed that semaglutide was associated with significantly lower risk of dementia and nicotine misuse versus other diabetes therapies, such as sitagliptin and glipizide

In comparison to FEHB and PSHB, CalPERS, which purchases health insurance for California state government employees, announced an average premium increase of 10.79% for 2025

Benefits of Foundayo For those in Columbus, Ohio, Foundayo offers a novel weight loss method with its convenient, once-daily oral dosing

This formula is suitable for vegetarians and is ideal for those who would like to provide their body with additional assistance to help reduce the harmful eff ects of metals, free radicals and other toxins.* This powdered, reduced glutathione has excellent absorbability

All peptides discussed in this guide are chemical reagents intended for laboratory research purposes only